skinny.

Latest / Stock Movers

Novo Nordisk's Pill, BMW's Struggle, Diageo Up

On this episode of Stock Movers:

- Novo Nordisk’s new Wegovy obesity pill fueled sales in the first quarter and the drugmaker said this year’s declines won’t be as bad as expected, a relief for investors.

- BMW’s carmaking returns fell in the first quarter as intense competition in China weighed on prices and deliveries in the world’s biggest auto market.

- Diageo’s sales unexpectedly rose in the latest quarter as growth in Africa and Latin America was enough to offset significant weakness in the US.

See omnystudio.com/listener for privacy information.

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.